Study With Amitriptylin to Evaluate the Efficacy of Melatonin in Treatment of Migraine
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of melatonin 3 mg compared to
placebo and amitriptyline 25 mg in the preventive treatment of migraine.
Phase:
Phase 3
Details
Lead Sponsor:
Hospital Israelita Albert Einstein
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Treatments:
Amitriptyline Amitriptyline, perphenazine drug combination Melatonin